EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape

Dong Chan Joo iD, Gwang Ha Kim iD

Gut and Liver · 15.09.2025 · 19 (5) · 633-634

DOI: 10.5009/gnl250399 ↗

Kurz gefasst

Editorial in der Zeitschrift Gut and Liver, erschienen am 15.09.2025. Verfasst von Dong Chan Joo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
  • Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.

ORCID-Profile: Dong Chan Joo, Gwang Ha Kim

Zitieren

APA

Joo, D. C., & Kim, G. H. (2025). Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape. Gut and Liver, 19(5), 633-634. https://doi.org/10.5009/gnl250399

Vancouver

Joo DC, Kim GH. Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape. Gut and Liver. 2025;19(5):633-634. doi:10.5009/gnl250399

BibTeX
@article{Joo2025,
  author = {Joo, Dong Chan and Kim, Gwang Ha},
  title = {Fexuprazan for the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer: A New Player in the Gastroprotection Landscape},
  journal = {Gut and Liver},
  year = {2025},
  volume = {19},
  number = {5},
  pages = {633--634},
  doi = {10.5009/gnl250399}
}
Kostenlos starten →